Difficulty: Medium
Average Score: 66%
Practice
Which of the following drugs is a folic acid antagonist:
Correct answer
C
Rationale
In this question, the correct answer is C) Co-trimoxazole (TMP-SMX). Co-trimoxazole is a combination antibiotic that includes sulfamethoxazole, a sulfonamide, which acts as a folic acid antagonist. This drug inhibits the synthesis of folic acid in bacteria by blocking dihydropteroate synthase, an enzyme involved in folic acid production.
Option A) Clindamycin is a lincosamide antibiotic that works by inhibiting protein synthesis in bacteria, not by acting as a folic acid antagonist.
Option B) Tetracycline is a broad-spectrum antibiotic that inhibits protein synthesis in bacteria by binding to the 30S ribosomal subunit, not by blocking folic acid synthesis.
Option D) Gentamicin is an aminoglycoside antibiotic that disrupts protein synthesis in bacteria by binding to the 30S ribosomal subunit, not by inhibiting folic acid production.
Understanding the mechanism of action of different antibiotics is crucial for healthcare professionals when selecting the appropriate drug for treating infections. Knowing that Co-trimoxazole acts as a folic acid antagonist helps in targeting specific types of bacteria that are susceptible to this mechanism, thus improving treatment outcomes and reducing the development of antibiotic resistance.
Option A) Clindamycin is a lincosamide antibiotic that works by inhibiting protein synthesis in bacteria, not by acting as a folic acid antagonist.
Option B) Tetracycline is a broad-spectrum antibiotic that inhibits protein synthesis in bacteria by binding to the 30S ribosomal subunit, not by blocking folic acid synthesis.
Option D) Gentamicin is an aminoglycoside antibiotic that disrupts protein synthesis in bacteria by binding to the 30S ribosomal subunit, not by inhibiting folic acid production.
Understanding the mechanism of action of different antibiotics is crucial for healthcare professionals when selecting the appropriate drug for treating infections. Knowing that Co-trimoxazole acts as a folic acid antagonist helps in targeting specific types of bacteria that are susceptible to this mechanism, thus improving treatment outcomes and reducing the development of antibiotic resistance.